v2.4.0.6
Schedule of Assets and Liabilities Measured at Fair Value as Reported in Consolidated Balance Sheet (Detail) (USD $)
In Thousands, unless otherwise specified
Dec. 23, 2012
Jun. 24, 2012
Financial Instruments [Line Items]    
Cash Equivalents $ 886,482 $ 1,325,361
Short-Term Investments 1,330,498 1,297,931
Restricted Cash and Investments 164,885 164,885
Prepaid Expenses and Other Current Assets 3,645 5,020
Other Assets 25,485 23,667
Total Assets 2,410,995 2,816,864
Accrued Expenses and Other Current Liabilities 465 4,328
Other Non-current Liabilities 250 201
Total Liabilities 715 4,529
Quoted Prices in Active Markets for Identical Assets (Level 1)
    
Financial Instruments [Line Items]    
Cash Equivalents 884,982 1,318,812
Short-Term Investments 173,974 130,624
Restricted Cash and Investments 164,885 164,885
Other Assets 25,485 23,667
Total Assets 1,249,326 1,637,988
Significant Other Observable Inputs (Level 2)
    
Financial Instruments [Line Items]    
Cash Equivalents 1,500 6,549
Short-Term Investments 1,156,524 1,167,307
Prepaid Expenses and Other Current Assets 3,645 5,020
Total Assets 1,161,669 1,178,876
Accrued Expenses and Other Current Liabilities 465 4,328
Total Liabilities 465 4,328
Significant Unobservable Inputs (Level 3)
    
Financial Instruments [Line Items]    
Other Non-current Liabilities 250 201
Total Liabilities $ 250 $ 201